Tesla, Europe and sales
Digest more
Top News
Impacts
Risks
Tesla’s sales were down 43% compared to 2024, which was already a bad year for Tesla.
From Electrek
Sales of Elon Musk’s chunky truck in the year’s first three months were less than half of what it delivered in Q3 and Q4 of last year, according to Cox Automotive.
From Forbes
The Chinese government could target Tesla as leverage in a trade war with the U.S.
From The Motley Fool
Read more on News Digest
3d
Dagens.com on MSNTesla Sales Nosedive Across Europe Amid Growing Backlash Against Elon MuskAcross key European markets, the automaker is facing a dramatic decline in sales, complicated by political controversies surrounding CEO Elon Musk and mounting competition from rivals, particularly Chinese manufacturers.
Sales in Europe appear to be plunging — down 42% in the first two months of 2025. Now one company appears to be capitalizing on Tesla's missteps.
Tesla's sales in key European markets fell again in March, data showed on Tuesday, adding to signs that drivers are shunning Elon Musk's electric car brand as competition from China stiffens and some protest against his political views.
EV maker Tesla's latest numbers for Sweden, Denmark, and the Netherlands are down over 60% in March, but TSLA stock is doing fine.
Another tempting Chinese Model Y rival in Europe is the Xpeng G6. Its base price in Germany is €47,600, which gets you a single-motor G6 with 296 hp and a 66 kWh battery. The small battery nets the base G6 a WLTP range of 270 miles (435 km), which can be increased up to 354 miles (570 km) with the optional 87.5 kWh battery.
4dOpinion
Grist on MSNWhat Tesla’s massive image problem means for the world’s transition to EVsTesla has long been a leader in the electric vehicles market. Now it's facing mounting protests and plummeting sales.
Shares of Tesla fell more than 2% on Wednesday as the company recorded a bigger-than-expected drop in sales in the January-March period.
"We believe the whole trajectory of earnings for TSLA remains too high and could face negative revisions post 1Q25 results," UBS analysts said.